15 June 2020 - Deborah Wilkes
Mundipharma, Ascendis Health, Lonza and McKesson have all announced people changes.
Mundipharma names chief executive
The Mundipharma network has appointed Allergan’s Marc Princen as global chief executive officer.
Princen will be responsible for all Mundipharma strategic and operational matters globally.
He joins from Allergan International where he was president and executive vice president of the international business. He has also worked for Merck & Co, Schering-Plough and Takeda.
Mundipharma is a global network of privately-owned independently-associated companies with a presence in Africa, Asia-Pacific, Canada, Europe, Latin America and the Middle East, but not the US.
Ascendis loses chief financial officer
Ascendis Health has announced the resignation of chief financial officer Kieron Futter with effect from 30 September 2020.
Futter joined the South African company in September 2015.
Lonza appoints chief executive
Switzerland’s Lonza has recruited Roche’s Pierre-Alain Ruffieux as chief executive officer with effect from 1 November 2020.
Ruffieux is currently Roche’s head of global pharma technical operations overseeing a team of 12,000 people. He has also worked for Novartis.
He takes over from Albert Baehny who was appointed interim chief executive officer in November 2019 following the resignation of Marc Funk for “personal reasons”. Baehny will return to his role as non-executive chairman.
McKesson promotes Rodgers
McKesson has promoted Tom Rodgers to executive vice president and chief strategy and business development officer.
In his new role, Rodgers is a member of the US drug distributor’s executive operating team.
He replaces Bansi Nagji who stepped down from the post on 31 March 2020.
Rodgers was previously senior vice president and managing director of McKesson Ventures.